Research News

The future of minority health and health disparities research is here: NIH

  • Posted on: 2 February 2019
  • By: Shalini.Sharma

Health disparities have persisted, despite extensive research and a decades-long mandate to eliminate them. Thus, the National Institute on Minority Health and Health Disparities (NIMHD) led a National Institutes of Health-wide, two-year science visioning process to chart a new research course to improve minority health and reduce health disparities. The American Journal of Public Health (AJPH) special issue  New Perspectives to Advance Minority Health and Health Disparities Research, is the culmination of this process with input from experts to help NIH determine the science needed to address health disparities. Thirty specific research strategies were identified across the three pillars that guided the science visioning: methods and measurement, etiology, and interventions.

CVMP initiates review of withdrawal periods of certain tylosin injectable products used in pigs

  • Posted on: 30 January 2019
  • By: Shalini.Sharma

Committee for Medicinal Products for Veterinary Use (CVMP) adopted by consensus a positive opinion for a type II variation application (subject to a worksharing procedure) for Purevax RC, Purevax RCP, Purevax RCP FeLV, Purevax RCPCh FeLV and Purevax RCPCh concerning quality changes.

Investigational monoclonal antibody to treat Ebola is safe in adults : NIH

  • Posted on: 30 January 2019
  • By: Shalini.Sharma

The investigational Ebola treatment mAb114 is safe, well-tolerated, and easy to administer, according to findings from an early-stage clinical trial published in The Lancet. Eighteen healthy adults received the monoclonal antibody as part of a Phase 1 clinical trial that began in May 2018 at the National Institutes of Health (NIH) Clinical Center in Bethesda, Maryland. The National Institute of Allergy and Infectious Diseases (NIAID) Vaccine Research Center (VRC), part of NIH, developed the investigational treatment and conducted and sponsored the clinical trial.

Smoking linked to higher risk of peripheral artery disease in African-Americans : Study

  • Posted on: 25 January 2019
  • By: Shalini.Sharma

African-Americans who smoke appear to be at greater risk for peripheral artery disease, or PAD, new research has found. Additionally, the findings suggest that smoking intensity – how many cigarettes a day and for how many years – also affects the likelihood of getting the disease.

Blood test shows promise for early detection of severe lung-transplant rejection: NIH

  • Posted on: 25 January 2019
  • By: Shalini.Sharma

Researchers have developed a simple blood test that can detect when a newly transplanted lung is being rejected by a patient, even when no outward signs of the rejection are evident. The test could make it possible for doctors to intervene faster to prevent or slow down so-called chronic rejection—which is severe, irreversible, and often deadly—in those first critical months after lung transplantation. Researchers believe this same test might also be useful for monitoring rejection in other types of organ transplants. The work was funded by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health.

Apple Inc joined with J&J to improve health outcomes of atrial fibrillation including stroke prevention

  • Posted on: 25 January 2019
  • By: PharmaTutor News

Johnson & Johnson entered into a research study in collaboration with Apple Inc. to investigate whether a new heart health program using an app from Johnson & Johnson in combination with Apple Watch’s irregular rhythm notifications and ECG app can accelerate the diagnosis and improve health outcomes of the 33 million people worldwide living with atrial fibrillation (AFib), a condition that can lead to stroke and other potentially devastating complications. In the U.S. alone, AFib is responsible for approximately 130,000 deaths and 750,000 hospitalizations every year.

NIH researchers rescue photoreceptors, prevent blindness in animal models of retinal degeneration

  • Posted on: 17 January 2019
  • By: Shalini.Sharma

Using a novel patient-specific stem cell-based therapy, researchers at the National Eye Institute (NEI) prevented blindness in animal models of geographic atrophy, the advanced "dry" form of age-related macular degeneration (AMD), which is a leading cause of vision loss among people age 65 and older. The protocols established by the animal study, published January 16 in Science Translational Medicine (STM), set the stage for a first-in-human clinical trial testing the therapy in people with geographic atrophy, for which there is currently no treatment.

NIH study implicates hyperactive immune system in aging brain disorders

  • Posted on: 8 January 2019
  • By: Shalini.Sharma

In a study of fruit flies, NIH scientists suggested that the body’s immune system may play a critical role in the damage caused by aging brain disorders. The results are based on experiments in which the researchers altered the activity of Cdk5, a gene that preclinical studies have suggested is important for early brain development and may be involved in neurodegenerative diseases, such as ALS, Alzheimer’s and Parkinson’s disease.

Pages